project id: TCGA-BRCA; case submitter id: TCGA-A8-A0A1; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.4; spectrophotometer method: UV Spec; age at index: 84; days to birth: -30742; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1925; age at diagnosis: 30742; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 365.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 241; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-A8-A0A1-01A-11; percent lymphocyte infiltration: 10.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0;